DERAMAXX FLAVOR TABS DIN 02265788
Status: Marketed
Holder: ELANCO CANADA LIMITED
Health Canada record
| Active ingredient(s) | DERACOXIB 100 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 09-Oct-2005 |
|---|
| Current status date | 01-Nov-2016 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DERACOXIB
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02265761 | DERAMAXX FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | DERACOXIB 25 MG | Marketed |
| 02328720 | DERAMAXX FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | DERACOXIB 75 MG | Marketed |
| 02392690 | DERAMAXX FLAVOR TABS | ELANCO CANADA LIMITED | Tablet | DERACOXIB 12 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 17511 | 2015-11-24 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 13597 | 2012-08-29 | Supplement to a New Drug Submission (SNDS) | Additional Claim |
| 13409 | 2012-06-22 | Supplement to a New Drug Submission (SNDS) | Site transfer of manufacturing, packaging, labelling and testing |
| 8977 | 2007-08-10 | Supplement to a New Drug Submission (SNDS) | ALTERNATE MANUFACTURING SITE FOR THE DRUG SUBSTANCE |
| 6318 | 2005-03-07 | New Drug Submission (NDS) | |
Request a quote for DERAMAXX FLAVOR TABS
How to read a Canadian DIN record